0:00
/
0:00

Paid episode

The full episode is only available to paid subscribers of Ryan Bailey's S&P Edge

Cannabis Stocks Surge on Trump's Rescheduling Announcement

A trader's breakdown of the market reaction, the key stocks to watch, and how I'm playing the news with the MSOS ETF

Hey everyone,

Did you feel that rumble in the market today? A news flash just sent the entire cannabis industry into overdrive, and stocks are popping everywhere.

The catalyst? It looks like President Trump announced during a press conference that the administration is looking to reschedule cannabis. Specifically, they are considering moving it from a Schedule 1 classification down to a Schedule 3.

Now, why is this such a massive deal? A move to Schedule 3 would federally recognize cannabis as having an accepted medical use. This would put it in the same category as substances like ketamine and testosterone, which are widely accessible in clinics. A change like this would have huge implications for scientific research, and it could also dramatically loosen criminal justice standards, which is desperately needed. For the industry, this could be the first major step toward ultimately ending federal prohibition.

Share

This post is for paid subscribers